[ad_1] CNBC’s Jim Cramer said that three corporate deals announced on Monday helped push stocks up. “Mergers matter. When companies start buying each other at a big premium to what the market’s willing to pay, it tells you that stocks entirely, the whole market, may just be too cheap,” he …
Read More »Horizon Therapeutics, Coupa Software, Weber and more
[ad_1] Check out the companies making headlines in midday trading. Horizon Therapeutics – Shares of the drugmaker jumped 15% after the company announced it has agreed to be acquired by Amgen in a deal valued at approximately $26.4 billion, or $116.50 per share, in cash. The deal will give Amgen a chance …
Read More »Lyft, Tripadvisor, Take-Two Interactive and more
[ad_1] Check out the companies making headlines in midday trading. Lyft – Shares of Lyft plummeted 21% after the company’s earnings report showed mixed results in the last quarter. The rideshare company reported adjusted earnings per share of 10 cents, more than analysts’ expectations of 7 cents, but revenue fell …
Read More »Wynn Resorts, TuSimple, Newell Brands, First Solar and more
[ad_1] This photograph taken on October 20, 2022 shows the signage of Wynn Casino resort with the Grand Lisboa and Casino Lisboa in the backdrop in Macau. Eduardo Leal | AFP | Getty Images Check out the companies making headlines in midday trading. Wynn Resorts — Shares of the casino …
Read More »Sell biopharma stock Amgen ahead of its obesity drug update, Barclays says
[ad_1] Investors should sell biopharma stock Amgen ahead of its obesity drug update Nov. 7, according to Barclays. Analyst Carter Gould downgraded Amgen to underweight from equal weight, saying there are high expectations around its obesity drug AMG133 after the stock rallied 21.5% in October. Amgen holds an analyst call …
Read More »Amgen, Uber, Lyft, Zscaler and more
[ad_1] A sign marks a rendezvous location for Lyft and Uber users at San Diego State University in San Diego, California, May 13, 2020. Mike Blake | Reuters Check out the companies making headlines in midday trading. Amgen — The biopharma stock jumped 5.7% after Morgan Stanley upgraded Amgen to …
Read More »